Biopharmaceutical giant Bristol-Myers Squibb Company (NYSE:BMY) is all set to report its first quarter 2012 results before the start of trading on April 26, 2012. The Zacks Consensus Estimate for the first quarter of 2012 is 61 cents (year-over-year increase of 5.2%) on revenues of $5,261 million (year-over-year increase of 5.0%).
Fourth Quarter Recap
Bristol-Myers’ fourth quarter 2011 adjusted earnings of 53 cents per share fell short of the Zacks Consensus Estimate by 2 cents. Adjusted … [visit site to read more] or compare Credit Card Rewards and Best Credit Cards